Company / Accounts Receivable
Pediatrix Medical Group Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$229.7M
FY2025
5-year range
$229.7M / $301.8M
FY2021-FY2025
Trend
-11.7%
vs FY2024
Sector context
#66 of 138
Health Care
What the data says
At $230M, Pediatrix Medical Group's accounts receivable ranks #66 of 138 in the Health Care sector. Accounts Receivable has declined for 4 consecutive years, from $302M in FY2021 to $230M in FY2025.
Based on SEC 10-K filings.
$230M in FY2025 with a 5-year CAGR of -1.0%.
Declined from $272M to $230M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -8.2%
- 5-Year CAGR
- -1.0%
- 10-Year CAGR
- -
Sector benchmark
#66 of 138 in Health CareTop 48% of 138This company $229.7M Sector average $1.3B
▼
-82.6% below sector average
Key checks
Key Insights
- Pediatrix Medical Group's accounts receivable has declined for 4 consecutive years.
- 5-year CAGR of -1.0%, indicating a declining trend.
- In FY2025, accounts receivable decreased 11.7% year-over-year.
- Ranks #66 out of 138 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.65 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $229.7M | -11.7% |
| FY2024 | $260.0M | -4.5% |
| FY2023 | $272.3M | -8.2% |
| FY2022 | $296.8M | -1.7% |
| FY2021 | $301.8M | +24.7% |
| FY2020 | $241.9M | -44.3% |
| FY2019 | $434.3M | -14.3% |
| FY2018 | $506.7M | +0.5% |
| FY2017 | $504.0M | +1.8% |
| FY2016 | $495.3M | +11.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026